SCMP

Sucampo Pharmaceuticals, Inc. News Headlines

$15.34
*  
0.63
3.94%
Get SCMP Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading SCMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SCMP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Can The Uptrend Continue for Sucampo (SCMP)? - Tale of the Tape
1/28/2015 9:16:41 AM - Zacks.com


Sucampo Pharmaceuticals: A Healthy 100% Share Price Jump In 3 Months
1/27/2015 4:37:00 AM - Seeking Alpha


Shire's Elvanse Gets Positive Response for ADHD in Adults - Analyst Blog
1/26/2015 5:20:00 PM - Zacks.com


Shire's Elvanse Gets Positive Response for ADHD in Adults - Analyst Blog
1/26/2015 5:20:00 AM - Investopedia


Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog
1/21/2015 5:35:00 PM - Zacks.com


Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog
1/21/2015 5:35:00 AM - Investopedia


RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog
1/6/2015 4:00:00 PM - Zacks.com


RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog
1/6/2015 4:00:00 AM - Investopedia


Cempra Reports Positive Results on Antibiotic Solithromycin - Analyst Blog
1/5/2015 5:25:00 PM - Zacks.com


Cempra Reports Positive Results on Antibiotic Solithromycin - Analyst Blog
1/5/2015 5:25:00 AM - Investopedia


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 PM - Zacks.com


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 AM - Investopedia


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 AM - Investopedia


ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog
12/31/2014 2:35:00 PM - Investopedia


ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog
12/31/2014 2:35:00 PM - Zacks.com


Alexion Seeks FDA Approval for its Hypophosphatasia Drug - Analyst Blog
12/31/2014 11:05:00 AM - Investopedia


Alexion Seeks FDA Approval for its Hypophosphatasia Drug - Analyst Blog
12/31/2014 11:05:00 AM - Zacks.com


Health Care Sector Update for 12/31/2014: RDHL, SCMP, MYL
12/31/2014 8:39:50 AM - MT Newswires


ARIA Widens Sales Turf, NRX Skips A Beat, NDRM Triples On Parkinson''s Study
12/30/2014 11:22:00 PM - RTT News


ARIA Widens Sales Turf, NRX Skips A Beat, NRDM Triples On Parkinson's Study
12/30/2014 11:12:00 PM - RTT News


Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst Blog
12/23/2014 4:35:00 PM - Zacks.com


Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst Blog
12/23/2014 4:35:00 AM - Investopedia


Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog
12/22/2014 4:12:00 PM - Zacks.com


Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog
12/22/2014 4:12:00 AM - Investopedia


Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog
12/18/2014 4:45:00 PM - Zacks.com